FindTrial
Sign In

Effects of dexmedetomidine and propofol in adult patients

Effects of dexmedetomidine and propofol during device closure of cardiac septal defects assisted by fluoroscopy in adult patients; A pilot study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000166
Enrollment
20
Registered
2011-08-12
Start date
2011-08-15
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients aged from 21 to 65 undergoing device closure of cardiac septal defects assisted by fluoroscopy

Exclusion criteria

Exclusion criteria: 1) The patient does not consent to participate in the study 2) Patients with a history of hypersensitivity reactions or side effects on propofol, opioid analgesics, or dekmedetomidin 3) bradycardia (less than 50 times per minute), hypotension (systolic blood pressure <90 mmHg) 4) second-degree or third-degree heart block, acute angina, congestive heart failure 5) patients who have drug dependence 6) pregnant women, or have liver or renal dysfunction

Design outcomes

Primary

MeasureTime frame
sedation state;satisfaction of patient and practitioner—

Secondary

MeasureTime frame
blood pressure;respiratory variable—

Countries

Korea, Republic of

Contacts

Public ContactYOONJI CHOI

Asan Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026